Halozyme Therapeutics, Inc.
HALO· Nasdaq
HALOHalozyme Therapeutics, Inc.
Quarterly figures for Halozyme Therapeutics, Inc., with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Halozyme Therapeutics, Inc. has filed its 10-Q within 31 to 41 days of period end across its last 8 quarters. The 10-K runs 48 to 55 days.
Halozyme Therapeutics, Inc. · CIK 1159036 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | $481.00M | +47.7% | $1.90 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 11, 2026 · after-hours |
| May 11, 2026 |
| 41 d |
| 10-Q |
| $376.71M |
| +42.2% |
| $1.22 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 17, 2026 · after-hours | Feb 17, 2026 | 48 d | 10-K | $451.77M | +51.6% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 3, 2025 · after-hours | Nov 3, 2025 | 34 d | 10-Q | $354.26M | +22.1% | $1.43 | |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 · after-hours | Aug 5, 2025 | 36 d | 10-Q | $325.72M | +40.8% | $1.33 | |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · after-hours | May 6, 2025 | 36 d | 10-Q | $264.86M | +35.2% | $0.93 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 18, 2025 · after-hours | Feb 18, 2025 | 49 d | 10-K | $298.01M | +29.5% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 31, 2024 · after-hours | Oct 31, 2024 | 31 d | 10-Q | $290.08M | +34.3% | $1.05 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · after-hours | Aug 6, 2024 | 37 d | 10-Q | $231.35M | +4.7% | $0.72 | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · after-hours | May 7, 2024 | 37 d | 10-Q | $195.88M | +20.8% | $0.60 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 20, 2024 · after-hours | Feb 20, 2024 | 51 d | 10-K | $230.04M | +26.7% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · after-hours | Nov 6, 2023 | 37 d | 10-Q | $216.03M | +3.4% | $0.61 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 8, 2023 | 39 d | 10-Q | $221.04M | +45.1% | $0.56 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · after-hours | May 9, 2023 | 39 d | 10-Q | $162.14M | +38.3% | $0.29 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 21, 2023 · after-hours | Feb 21, 2023 | 52 d | 10-K | $181.50M | +77.9% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | $208.98M | +80.4% | $0.44 | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | $152.37M | +11.7% | $0.16 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | $117.28M | +31.7% | $0.43 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 22, 2022 · after-hours | Feb 22, 2022 | 53 d | 10-K | $102.00M | −16.2% | — | |
| Q3 2021 | Sep 30, 2021 | Nov 2, 2021 · after-hours | Nov 2, 2021 | 33 d | 10-Q | $115.83M | +77.3% | $1.48 | |
| Q2 2021 | Jun 30, 2021 | Aug 9, 2021 · after-hours | Aug 9, 2021 | 40 d | 10-Q | $136.46M | +147.1% | $0.62 | |
| Q1 2021 | Mar 31, 2021 | May 10, 2021 · after-hours | May 10, 2021 | 40 d | 10-Q | $89.02M | +251.1% | $0.19 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | Feb 23, 2021 · after-hours | Feb 23, 2021 | 54 d | 10-K | $121.70M | +126.8% | $0.50 | |
| Q3 2020 | Sep 30, 2020 | Nov 2, 2020 · after-hours | Nov 2, 2020 | 33 d | 10-Q | $65.32M | +41.3% | $0.25 | |
| Q2 2020 | Jun 30, 2020 | Aug 10, 2020 · after-hours | Aug 10, 2020 | 41 d | 10-Q | $55.22M | +41.1% | $0.19 | |
| Q1 2020 | Mar 31, 2020 | May 11, 2020 · after-hours | May 11, 2020 | 41 d | 10-Q | $25.35M | −55.5% | -$0.04 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | Feb 24, 2020 · after-hours | Feb 24, 2020 | 55 d | 10-K | $53.67M | −10.9% | -$0.24 | |
| Q3 2019 | Sep 30, 2019 | Nov 12, 2019 · after-hours | Nov 12, 2019 | 43 d | 10-Q | $46.23M | +80.9% | -$0.17 | |
| Q2 2019 | Jun 30, 2019 | Aug 6, 2019 · after-hours | Aug 6, 2019 | 37 d | 10-Q | $39.15M | +11.2% | -$0.10 | |
| Q1 2019 | Mar 31, 2019 | May 7, 2019 · after-hours | May 7, 2019 | 37 d | 10-Q | $56.95M | +84.5% | $0.01 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | Feb 21, 2019 · after-hours | Feb 21, 2019 | 52 d | 10-K | $60.23M | −68.2% | -$0.01 | |
| Q3 2018 | Sep 30, 2018 | Nov 6, 2018 · after-hours | Nov 6, 2018 | 37 d | 10-Q | $25.56M | −59.9% | -$0.19 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 7, 2018 | 38 d | 10-Q | $35.20M | +4.3% | -$0.16 | |
| Q1 2018 | Mar 31, 2018 | — | May 10, 2018 | 40 d | 10-Q | $30.87M | +4.4% | -$0.19 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Feb 20, 2018 | 51 d | 10-K | $189.56M | +386.0% | $850.00 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 7, 2017 | 38 d | 10-Q | $63.73M | +100.1% | $20.00 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 8, 2017 | 39 d | 10-Q | $33.75M | +1.2% | -$230.00 | |
| Q1 2017 | Mar 31, 2017 | — | May 9, 2017 | 39 d | 10-Q | $29.57M | −30.4% | -$260.00 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Feb 28, 2017 | 59 d | 10-K | $39.00M | ±0.0% | $0.03 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 7, 2016 | 38 d | 10-Q | $31.85M | ±0.0% | -$0.23 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 9, 2016 | 40 d | 10-Q | $33.34M | ±0.0% | $0.02 | |
| Q1 2016 | Mar 31, 2016 | — | May 9, 2016 | 39 d | 10-Q | $42.50M | ±0.0% | -$0.12 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Feb 29, 2016 | 60 d | 10-K | $39.00M | +28.4% | $0.03 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 9, 2015 | 40 d | 10-Q | $31.85M | +118.1% | -$0.19 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 10, 2015 | 41 d | 10-Q | $33.34M | +81.3% | $0.02 | |
| Q1 2015 | Mar 31, 2015 | — | May 11, 2015 | 41 d | 10-Q | $42.50M | +255.2% | -$0.12 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | Mar 2, 2015 | 61 d | 10-K | $30.38M | +143.0% | -$0.04 | |
| Q3 2014 | Sep 30, 2014 | — | Nov 10, 2014 | 41 d | 10-Q | $14.61M | −8.8% | -$0.16 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 11, 2014 | 42 d | 10-Q | $18.39M | +27.2% | -$0.13 | |
| Q1 2014 | Mar 31, 2014 | — | May 12, 2014 | 42 d | 10-Q | $11.97M | +1.1% | -$0.22 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | Feb 28, 2014 | 59 d | 10-K | $12.50M | −42.6% | -$0.19 | |
| Q3 2013 | Sep 30, 2013 | — | Nov 8, 2013 | 39 d | 10-Q | $16.01M | +200.2% | -$0.17 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 7, 2013 | 38 d | 10-Q | $14.45M | +86.3% | -$0.20 | |
| Q1 2013 | Mar 31, 2013 | — | May 8, 2013 | 38 d | 10-Q | $11.83M | +59.0% | -$0.17 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | Mar 1, 2013 | 60 d | 10-K | $21.79M | +803.9% | -$0.04 | |
| Q3 2012 | Sep 30, 2012 | — | Nov 8, 2012 | 39 d | 10-Q | $5.33M | −76.7% | -$0.18 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 9, 2012 | 40 d | 10-Q | $7.76M | −66.5% | -$0.13 | |
| Q1 2012 | Mar 31, 2012 | — | May 7, 2012 | 37 d | 10-Q | $7.44M | −1.4% | -$0.14 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2011 | — | Mar 12, 2012 | 72 d | 10-K | $2.41M | — | -$0.18 | |
| Q3 2011 | Sep 30, 2011 | — | Nov 8, 2011 | 39 d | 10-Q | $22.94M | +575.5% | $0.05 | |
| Q2 2011 | Jun 30, 2011 | — | Aug 5, 2011 | 36 d | 10-Q | $23.19M | +621.6% | $0.03 | |
| Q1 2011 | Mar 31, 2011 | — | May 6, 2011 | 36 d | 10-Q | $7.54M | — | -$0.10 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | — | — | — | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $3.40M | — | -$0.13 | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $3.21M | — | -$0.13 | |
